0001209191-17-046024.txt : 20170721
0001209191-17-046024.hdr.sgml : 20170721
20170721195850
ACCESSION NUMBER: 0001209191-17-046024
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170719
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Arbuckle Stuart A
CENTRAL INDEX KEY: 0001557290
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17977401
MAIL ADDRESS:
STREET 1: VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-19
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001557290
Arbuckle Stuart A
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP\Chief Commercial Officer
Common Stock
2017-07-19
4
M
0
25500
96.87
A
156967
D
Common Stock
2017-07-19
4
M
0
38250
109.14
A
195217
D
Common Stock
2017-07-19
4
M
0
14875
131.89
A
210092
D
Common Stock
2017-07-19
4
M
0
10775
91.05
A
220867
D
Common Stock
2017-07-19
4
S
0
60400
161.00
D
160467
D
Common Stock
2017-07-19
4
S
0
29000
162.67
D
131467
D
Common Stock
2017-07-21
4
M
0
2125
131.89
A
133592
D
Common Stock
2017-07-21
4
S
0
2125
159.00
D
131467
D
Common Stock
2017-07-21
4
S
0
10150
161.68
D
121317
D
Common Stock
2017-07-21
4
S
0
200
161.72
D
121117
D
Common Stock
140
I
401(k)
Stock Option (Right to Buy)
96.87
2017-07-19
4
M
0
25500
0.00
D
2024-07-14
Common Stock
25500
8500
D
Stock Option (Right to Buy)
109.14
2017-07-19
4
M
0
38250
0.00
D
2025-02-02
Common Stock
38250
38250
D
Stock Option (Right to Buy)
131.89
2017-07-19
4
M
0
14875
0.00
D
2025-07-20
Common Stock
14875
19125
D
Stock Option (Right to Buy)
91.05
2017-07-19
4
M
0
10775
0.00
D
2026-02-01
Common Stock
10775
23707
D
Stock Option (Right to Buy)
131.89
2017-07-21
4
M
0
2125
0.00
D
2025-07-20
Common Stock
2125
17000
D
Transaction made pursuant to Mr. Arbuckle's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 07/15/2014.
The option vests in 16 quarterly installments from 02/03/2015.
The option vests in 16 quarterly installments from 07/21/2015.
The option vests in 16 quarterly installments from 02/02/2016.
Omar White, Attorney-In-Fact
2017-07-21